Jim Daly

Director

Jim Daly has served as a member of our Board of Directors since August 2025.

Mr. Daly brings more than 30 years of global biopharmaceutical leadership experience with particular expertise in commercialization to our Board of Directors.

Most recently, Mr. Daly served as the Chief Commercial Officer at Incyte Corporation and oversaw development of the company’s global commercial capabilities.

Previously, he spent 10 years at Amgen where he held multiple senior leadership positions, including Senior Vice President of North America Commercial Operations, and launched several successful medicines. He began his career at GlaxoSmithKline, serving in escalating positions of seniority throughout his 16-year tenure with the company.

Mr. Daly currently serves on the Boards of Madrigal Pharmaceuticals, argenx SE, and Acadia Pharmaceuticals.

He earned a B.S. in Pharmacy and an M.B.A. from the University at Buffalo, SUNY.